NEOMYCIN SULFATE

NEOMYCIN SULFATE was reported 2738 times

NEOMYCIN SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 21 0.2188
1 VAGINAL FLATULENCE 66 0.2178
2 UNWANTED AWARENESS DURING ANAESTHESIA 31 0.0945
3 PROLONGED EXPIRATION 21 0.0802
4 NAIL BED TENDERNESS 7 0.0614
5 NASAL OEDEMA 96 0.0531
6 FEMALE GENITAL TRACT FISTULA 75 0.0439
7 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 4 0.0381
8 SYNOVIAL FLUID ANALYSIS 3 0.0345
9 RHEUMATIC FEVER 136 0.0305
10 ONYCHOMYCOSIS 128 0.0291
11 ONYCHOMADESIS 118 0.0281
12 RADICULOPATHY 72 0.0273
13 ASPERGER'S DISORDER 2 0.0250
14 PROCTITIS 66 0.0235
15 CHRONIC SINUSITIS 84 0.0224
16 C-REACTIVE PROTEIN ABNORMAL 137 0.0213
17 HEPATIC ENZYME 3 0.0201
18 POST PROCEDURAL OEDEMA 4 0.0172
19 MACULAR DEGENERATION 202 0.0169
20 PTERYGIUM 5 0.0145
21 SYNOVIAL DISORDER 6 0.0132
22 GRIP STRENGTH 3 0.0131
23 LUPUS VULGARIS 16 0.0127
24 PEMPHIGUS 138 0.0110
25 TENOSYNOVITIS STENOSANS 6 0.0108
26 FACET JOINT SYNDROME 35 0.0107
27 DEEP VEIN THROMBOSIS POSTOPERATIVE 19 0.0095
28 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 6 0.0090
29 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 2 0.0089
30 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
31 VAGINAL SWELLING 3 0.0084
32 PERICARDITIS 138 0.0082
33 SYNOVITIS 141 0.0078
34 DUODENAL ULCER PERFORATION 58 0.0078
35 VULVAL OEDEMA 3 0.0076
36 FINGER DEFORMITY 34 0.0070
37 AUTONOMIC NEUROPATHY 7 0.0069
38 VAGINAL DISCHARGE 67 0.0066
39 C-REACTIVE PROTEIN 6 0.0065
40 VAGINAL BURNING SENSATION 3 0.0064
41 RETINITIS 11 0.0064
42 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
43 PARAKERATOSIS 2 0.0062
44 X-RAY ABNORMAL 11 0.0061
45 PARAESTHESIA ORAL 88 0.0061
46 DEPRESSIVE SYMPTOM 21 0.0060
47 ORAL CANDIDIASIS 77 0.0058
48 HELICOBACTER INFECTION 55 0.0053
49 GRIP STRENGTH DECREASED 47 0.0053
50 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 38 0.0053
51 DISLOCATION OF VERTEBRA 12 0.0053
52 TYPE 2 DIABETES MELLITUS 172 0.0051
53 WOUND 142 0.0051
54 FOLLICULITIS 53 0.0050
55 CONJUNCTIVITIS INFECTIVE 2 0.0049
56 HYPERCHOLESTEROLAEMIA 47 0.0049
57 SWOLLEN JOINT COUNT INCREASED 15 0.0047
58 PERIPHERAL VENOUS DISEASE 19 0.0046
59 LIVE BIRTH 37 0.0044
60 SYSTEMIC LUPUS ERYTHEMATOSUS 154 0.0043
61 CONTRAINDICATED PRODUCT ADMINISTERED 131 0.0043
62 BREAST CANCER STAGE III 28 0.0043
63 PRODUCT LABEL CONFUSION 25 0.0043
64 HAND DEFORMITY 56 0.0043
65 C-REACTIVE PROTEIN INCREASED 152 0.0042
66 ALLERGY TO CHEMICALS 5 0.0040
67 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 26 0.0040
68 MUSCLE INJURY 33 0.0040
69 BLEPHAROSPASM 25 0.0040
70 PSORIATIC ARTHROPATHY 154 0.0038
71 RESPIRATORY TRACT INFECTION 98 0.0038
72 SCLERITIS 6 0.0037
73 INFUSION RELATED REACTION 248 0.0037
74 TOXIC ANTERIOR SEGMENT SYNDROME 4 0.0037
75 CORNEAL ABRASION 5 0.0036
76 RHEUMATOID FACTOR POSITIVE 21 0.0036
77 THERAPEUTIC PRODUCT EFFECT DECREASED 162 0.0036
78 RALES 21 0.0036
79 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 2 0.0036
80 SERONEGATIVE ARTHRITIS 4 0.0035
81 BURSITIS 42 0.0035
82 LIP DRY 31 0.0034
83 BONE EROSION 12 0.0034
84 THERAPEUTIC PRODUCT CROSS-REACTIVITY 3 0.0034
85 GASTROINTESTINAL BACTERIAL OVERGROWTH 2 0.0033
86 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 228 0.0032
87 RESPIRATION ABNORMAL 22 0.0032
88 APPETITE DISORDER 21 0.0032
89 JOINT RANGE OF MOTION DECREASED 42 0.0031
90 ANIMAL SCRATCH 3 0.0031
91 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 2 0.0031
92 COELIAC DISEASE 30 0.0031
93 FLANK PAIN 28 0.0030
94 PROCEDURAL PAIN 82 0.0030
95 WHEEZING 174 0.0029
96 CORNEAL OPACITY 4 0.0029
97 FIBROMYALGIA 71 0.0029
98 CUSHING'S SYNDROME 2 0.0029
99 FREQUENT BOWEL MOVEMENTS 76 0.0028
100 NAIL DISORDER 24 0.0027
101 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
102 KNEE DEFORMITY 4 0.0027
103 GLOSSODYNIA 59 0.0026
104 HERPES ZOSTER DISSEMINATED 2 0.0025
105 ADVERSE REACTION 33 0.0025
106 ILL-DEFINED DISORDER 150 0.0025
107 WOUND INFECTION 27 0.0025
108 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
109 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
110 HYDROTHORAX 2 0.0024
111 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
112 INCISION SITE COMPLICATION 2 0.0024
113 NORMAL NEWBORN 13 0.0024
114 CLOSTRIDIAL INFECTION 8 0.0024
115 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 2 0.0024
116 CREPITATIONS 7 0.0023
117 INFUSION SITE REACTION 7 0.0023
118 GASTROINTESTINAL FISTULA 2 0.0023
119 ENTEROCUTANEOUS FISTULA 2 0.0023
120 OEDEMA 123 0.0023
121 LARYNGOSPASM 6 0.0022
122 BACK INJURY 24 0.0022
123 CUSHINGOID 7 0.0022
124 RHEUMATOID NODULE 6 0.0022
125 PLEURITIC PAIN 6 0.0022
126 IRRITABLE BOWEL SYNDROME 46 0.0021
127 GENITAL RASH 3 0.0021
128 EXOSTOSIS 19 0.0021
129 SLEEP DISORDER 146 0.0021
130 RECTAL HAEMORRHAGE 88 0.0020
131 BACTERIAL VAGINOSIS 3 0.0019
132 JOINT SPRAIN 2 0.0019
133 SCIATICA 30 0.0019
134 LUPUS-LIKE SYNDROME 17 0.0019
135 AUTOIMMUNE DISORDER 18 0.0018
136 TREATMENT FAILURE 152 0.0018
137 SWELLING 171 0.0018
138 COLITIS 69 0.0018
139 VANISHING BILE DUCT SYNDROME 2 0.0018
140 TONSILLAR DISORDER 2 0.0018
141 INJECTION SITE REACTION 121 0.0018
142 PANCREATIC CARCINOMA METASTATIC 5 0.0018
143 BLOODY DISCHARGE 2 0.0017
144 COLITIS ULCERATIVE 78 0.0017
145 CARBON DIOXIDE DECREASED 2 0.0017
146 INCISION SITE PAIN 2 0.0017
147 IMPAIRED HEALING 55 0.0017
148 OTITIS EXTERNA 2 0.0016
149 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
150 BLOOD UREA DECREASED 2 0.0016
151 LIPOMA 4 0.0015
152 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17 0.0015
153 RHEUMATOID ARTHRITIS 174 0.0015
154 PERSONALITY DISORDER 4 0.0015
155 SYNOVIAL CYST 7 0.0015
156 CANDIDIASIS 6 0.0015
157 DYSPEPSIA 145 0.0015
158 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25 0.0015
159 INTESTINAL MASS 2 0.0015
160 ORAL FUNGAL INFECTION 4 0.0015
161 CROHN'S DISEASE 10 0.0015
162 HAEMATOCHEZIA 80 0.0014
163 ASTHMA 162 0.0014
164 NEUROGENIC BLADDER 3 0.0014
165 PHARYNGEAL ERYTHEMA 3 0.0014
166 NAIL INFECTION 2 0.0014
167 PORPHYRIA ACUTE 2 0.0014
168 REACTION TO DRUG EXCIPIENTS 3 0.0014
169 PANCREATIC ENZYMES INCREASED 2 0.0014
170 WALKING AID USER 9 0.0014
171 INCREASED UPPER AIRWAY SECRETION 7 0.0014
172 TOOTH DISCOLOURATION 4 0.0014
173 GENITAL PAIN 2 0.0014
174 LIVER INJURY 33 0.0013
175 OBESITY 21 0.0013
176 EYE INJURY 4 0.0013
177 FUNGAL PERITONITIS 2 0.0013
178 CONTRAINDICATION TO MEDICAL TREATMENT 2 0.0013
179 PULMONARY FIBROSIS 25 0.0013
180 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
181 FUNGAEMIA 2 0.0013
182 FOOT DEFORMITY 14 0.0013
183 NIGHT BLINDNESS 2 0.0012
184 ACUTE LEUKAEMIA 2 0.0012
185 HEPATIC CIRRHOSIS 23 0.0012
186 DEMENTIA ALZHEIMER'S TYPE 2 0.0012
187 GAIT INABILITY 40 0.0012
188 EROSIVE OESOPHAGITIS 2 0.0012
189 DEAFNESS BILATERAL 2 0.0012
190 WOUND COMPLICATION 4 0.0012
191 BLOOD CHOLESTEROL INCREASED 54 0.0012
192 DRUG-INDUCED LIVER INJURY 36 0.0011
193 LOWER LIMB FRACTURE 22 0.0011
194 MITRAL VALVE DISEASE 2 0.0011
195 OSTEOARTHRITIS 47 0.0011
196 INTENTIONAL PRODUCT USE ISSUE 96 0.0011
197 OPPORTUNISTIC INFECTION 2 0.0011
198 EPILEPSY 33 0.0011
199 CONFUSIONAL STATE 167 0.0010
200 OCULAR HYPERTENSION 2 0.0010
201 LIVER FUNCTION TEST INCREASED 22 0.0010
202 CONCOMITANT DISEASE PROGRESSION 2 0.0010
203 JOINT EFFUSION 7 0.0010
204 PATENT DUCTUS ARTERIOSUS 4 0.0010
205 PRESCRIBED UNDERDOSE 20 0.0010
206 UNDERDOSE 73 0.0010
207 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
208 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
209 TASTE DISORDER 20 0.0010
210 EAR PAIN 19 0.0010
211 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
212 STOMACH DISCOMFORT 5 0.0010
213 PHARYNGOLARYNGEAL PAIN 5 0.0009
214 ATELECTASIS 9 0.0009
215 PRESCRIBED OVERDOSE 18 0.0009
216 DEREALISATION 2 0.0009
217 INCOHERENT 6 0.0009
218 HEPATIC ENZYME INCREASED 63 0.0009
219 DRUG INTOLERANCE 89 0.0009
220 TONGUE DISCOLOURATION 4 0.0009
221 PULMONARY FUNCTION TEST DECREASED 4 0.0009
222 NIGHT SWEATS 29 0.0009
223 PSEUDOMEMBRANOUS COLITIS 2 0.0009
224 CHEST PAIN 164 0.0009
225 NASAL DISCOMFORT 7 0.0009
226 DERMATITIS CONTACT 10 0.0009
227 PUSTULAR PSORIASIS 3 0.0009
228 VISUAL DISTURBANCE 5 0.0009
229 ORAL PRURITUS 2 0.0009
230 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
231 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
232 STOMATITIS 52 0.0009
233 JOINT DISLOCATION 9 0.0009
234 VAGINAL INFECTION 4 0.0008
235 BREAST CANCER STAGE II 7 0.0008
236 JOINT STIFFNESS 22 0.0008
237 HYPOVOLAEMIC SHOCK 4 0.0008
238 INFLAMMATION 43 0.0008
239 FAECAL INCONTINENCE 4 0.0008
240 ORAL INTAKE REDUCED 2 0.0008
241 HEPATITIS 21 0.0008
242 EYE OEDEMA 2 0.0008
243 CARDIAC MURMUR 7 0.0008
244 ACUTE PSYCHOSIS 2 0.0008
245 MOBILITY DECREASED 58 0.0008
246 SUFFOCATION FEELING 2 0.0008
247 HYPERACUSIS 3 0.0008
248 INJECTION SITE ABSCESS 2 0.0008
249 PRODUCT USE ISSUE 151 0.0008
250 ANGINA PECTORIS 23 0.0008
251 HYPERAMMONAEMIA 4 0.0008
252 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
253 AMMONIA INCREASED 4 0.0008
254 BLISTER 44 0.0008
255 INJURY 55 0.0008
256 LACTOSE INTOLERANCE 2 0.0008
257 RHINOVIRUS INFECTION 3 0.0008
258 TENDERNESS 8 0.0008
259 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
260 PERSONALITY CHANGE 7 0.0008
261 DEFORMITY 7 0.0007
262 DRY MOUTH 60 0.0007
263 CHONDROPATHY 2 0.0007
264 EAR CONGESTION 2 0.0007
265 ULCERATIVE KERATITIS 2 0.0007
266 RHINALGIA 2 0.0007
267 TENOSYNOVITIS 2 0.0007
268 RASH MORBILLIFORM 2 0.0007
269 GENERAL PHYSICAL HEALTH DETERIORATION 83 0.0007
270 JOINT SWELLING 86 0.0007
271 PRODUCTIVE COUGH 34 0.0007
272 MALAISE 312 0.0007
273 ARTHROPATHY 39 0.0007
274 VENTRICULAR SEPTAL DEFECT 4 0.0007
275 ANOREXIA 9 0.0007
276 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
277 LIP PAIN 2 0.0007
278 METASTATIC NEOPLASM 3 0.0007
279 PHARYNGEAL DISORDER 2 0.0007
280 TOOTH INJURY 3 0.0007
281 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
282 ADENOVIRUS INFECTION 2 0.0007
283 NODULE 9 0.0007
284 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 33 0.0007
285 SINUSITIS 69 0.0007
286 HEARING IMPAIRED 4 0.0007
287 ACNE CYSTIC 2 0.0007
288 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0007
289 ERYTHEMA 136 0.0007
290 EXPOSURE DURING PREGNANCY 41 0.0007
291 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
292 PNEUMONIA 213 0.0007
293 PROSTATITIS 2 0.0007
294 MASTICATION DISORDER 2 0.0007
295 HIP ARTHROPLASTY 10 0.0007
296 LARYNGEAL OEDEMA 4 0.0006
297 TALIPES 2 0.0006
298 ROSACEA 3 0.0006
299 PAIN 395 0.0006
300 BLOOD BLISTER 2 0.0006
301 EAR INFECTION 17 0.0006
302 DYSPNOEA EXERTIONAL 24 0.0006
303 LUNG DISORDER 31 0.0006
304 BLOOD ALBUMIN DECREASED 5 0.0006
305 BLADDER PAIN 2 0.0006
306 ULCER 10 0.0006
307 PRODUCT USE IN UNAPPROVED INDICATION 155 0.0006
308 APHAGIA 3 0.0006
309 STUPOR 2 0.0006
310 ROAD TRAFFIC ACCIDENT 26 0.0006
311 LOOSE TOOTH 2 0.0006
312 SKIN EROSION 2 0.0006
313 PORTAL VEIN THROMBOSIS 2 0.0006
314 COUGH 173 0.0006
315 DYSPNOEA 345 0.0006
316 PANCREATIC DISORDER 3 0.0006
317 INJECTION SITE INFECTION 2 0.0006
318 EXPIRED DRUG ADMINISTERED 3 0.0006
319 DEPRESSED MOOD 32 0.0006
320 EXPOSURE DURING BREAST FEEDING 2 0.0006
321 WEIGHT DECREASED 168 0.0006
322 THERAPEUTIC AGENT TOXICITY 2 0.0006
323 ATRIAL SEPTAL DEFECT 5 0.0006
324 PYREXIA 206 0.0006
325 EMPHYSEMA 6 0.0006
326 SENSATION OF FOREIGN BODY 5 0.0006
327 ULCER HAEMORRHAGE 4 0.0006
328 DISCOMFORT 36 0.0006
329 TOOTH ABSCESS 6 0.0006
330 BRONCHOPNEUMONIA 2 0.0006
331 DIFFICULTY IN WALKING 2 0.0006
332 BLOOD MAGNESIUM DECREASED 5 0.0006
333 MULTI-ORGAN FAILURE 10 0.0006
334 FAILURE TO THRIVE 3 0.0006
335 TONSILLITIS 3 0.0006
336 MUSCULOSKELETAL PAIN 30 0.0006
337 GASTROINTESTINAL DISORDER 51 0.0006
338 RASH 248 0.0006
339 INCONTINENCE 6 0.0006
340 RESPIRATORY TRACT CONGESTION 9 0.0006
341 PULMONARY TOXICITY 4 0.0006
342 HEART DISEASE CONGENITAL 2 0.0006
343 PHARYNGITIS 7 0.0006
344 GLOSSITIS 2 0.0006
345 CONJUNCTIVAL HYPERAEMIA 2 0.0006
346 MUSCULOSKELETAL STIFFNESS 49 0.0006
347 DRUG EXPOSURE DURING PREGNANCY 19 0.0006
348 THERAPY NON-RESPONDER 25 0.0006
349 CHEILITIS 3 0.0006
350 DRUG ADMINISTRATION ERROR 17 0.0006
351 ANOSMIA 8 0.0006
352 SKIN LACERATION 6 0.0006
353 OPTIC NEURITIS 5 0.0005
354 SPONDYLITIS 2 0.0005
355 DELIRIUM 19 0.0005
356 BLOOD PHOSPHORUS DECREASED 2 0.0005
357 AMYLASE INCREASED 2 0.0005
358 GASTRIC ULCER HAEMORRHAGE 3 0.0005
359 LIVER DISORDER 24 0.0005
360 BRONCHITIS 40 0.0005
361 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
362 FEELING DRUNK 4 0.0005
363 FEELING JITTERY 10 0.0005
364 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
365 ABDOMINAL DISTENSION 54 0.0005
366 CONGENITAL ANOMALY 4 0.0005
367 SENSATION OF HEAVINESS 2 0.0005
368 SKIN ODOUR ABNORMAL 2 0.0005
369 DISABILITY 10 0.0005
370 PROTHROMBIN TIME PROLONGED 3 0.0005
371 HYPOAESTHESIA 75 0.0005
372 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
373 NASAL CONGESTION 29 0.0005
374 SPINAL FUSION SURGERY 2 0.0005
375 ANAEMIA 94 0.0005
376 DRY THROAT 5 0.0005
377 INFECTION 71 0.0005
378 OLIGURIA 3 0.0005
379 HYPOXIA 17 0.0005
380 ABDOMINAL PAIN 112 0.0005
381 ACCIDENTAL EXPOSURE 2 0.0005
382 PHOTOPHOBIA 9 0.0005
383 UNINTENDED PREGNANCY 5 0.0005
384 VOMITING 222 0.0005
385 ABDOMINAL DISCOMFORT 78 0.0005
386 RHINORRHOEA 30 0.0005
387 HORDEOLUM 2 0.0005
388 DYSURIA 17 0.0005
389 ACNE 35 0.0005
390 TENDON DISORDER 3 0.0005
391 NASOPHARYNGITIS 84 0.0005
392 HAEMORRHAGIC ANAEMIA 2 0.0005
393 ABDOMINAL ABSCESS 2 0.0005
394 BLOOD CREATINE INCREASED 2 0.0005
395 DRUG ERUPTION 8 0.0005
396 LUNG INFECTION 7 0.0005
397 LIP SWELLING 15 0.0004
398 RHINITIS ALLERGIC 2 0.0004
399 MENSTRUATION IRREGULAR 12 0.0004
400 POST-TRAUMATIC STRESS DISORDER 3 0.0004
401 BLOOD CALCIUM DECREASED 5 0.0004
402 HYPERTENSION 94 0.0004
403 PRODUCT LABEL ISSUE 3 0.0004
404 TACHYPNOEA 6 0.0004
405 OVERDOSE 95 0.0004
406 HAEMOGLOBIN INCREASED 2 0.0004
407 DROOLING 3 0.0004
408 INTENTIONAL DRUG MISUSE 9 0.0004
409 EYE SWELLING 16 0.0004
410 NECK PAIN 24 0.0004
411 GASTRITIS EROSIVE 2 0.0004
412 HEPATIC ENCEPHALOPATHY 4 0.0004
413 KNEE ARTHROPLASTY 9 0.0004
414 NAUSEA 338 0.0004
415 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
416 SKIN ABRASION 2 0.0004
417 THERMAL BURN 3 0.0004
418 FUNGAL INFECTION 14 0.0004
419 GESTATIONAL DIABETES 2 0.0004
420 ENDOMETRIOSIS 2 0.0004
421 DECREASED APPETITE 97 0.0004
422 CONSTIPATION 91 0.0004
423 GASTROINTESTINAL TOXICITY 2 0.0004
424 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
425 TONGUE DISORDER 3 0.0004
426 RASH VESICULAR 2 0.0004
427 OSTEOPOROSIS 17 0.0004
428 PRODUCT QUALITY ISSUE 56 0.0004
429 GASTROENTERITIS 6 0.0004
430 UTERINE LEIOMYOMA 3 0.0004
431 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
432 PAIN OF SKIN 11 0.0004
433 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
434 BODY TEMPERATURE DECREASED 4 0.0004
435 SMALL INTESTINAL OBSTRUCTION 5 0.0004
436 STEVENS-JOHNSON SYNDROME 9 0.0004
437 MUCOUS STOOLS 2 0.0004
438 MULTIPLE DRUG OVERDOSE 2 0.0004
439 ANEURYSM 2 0.0004
440 FLUID INTAKE REDUCED 2 0.0004
441 NEUROPATHY PERIPHERAL 38 0.0004
442 MIGRAINE 38 0.0004
443 KLEBSIELLA INFECTION 2 0.0004
444 DRUG INEFFECTIVE 520 0.0004
445 HAEMODYNAMIC INSTABILITY 3 0.0004
446 ACIDOSIS 3 0.0004
447 ENDOCARDITIS 2 0.0004
448 EAR DISCOMFORT 4 0.0004
449 HYPERSENSITIVITY 72 0.0004
450 HYPOALBUMINAEMIA 3 0.0004
451 APNOEA 3 0.0004
452 RED BLOOD CELL COUNT DECREASED 11 0.0004
453 MALABSORPTION 2 0.0004
454 ALOPECIA 75 0.0004
455 CHEST DISCOMFORT 39 0.0004
456 FOOD CRAVING 2 0.0004
457 SERUM FERRITIN INCREASED 2 0.0004
458 ADVERSE DRUG REACTION 34 0.0004
459 FURUNCLE 3 0.0004
460 MEMORY IMPAIRMENT 52 0.0004
461 CONJUNCTIVITIS 7 0.0004
462 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
463 URTICARIA 63 0.0004
464 THINKING ABNORMAL 7 0.0004
465 IMPAIRED WORK ABILITY 8 0.0004
466 CONTUSION 36 0.0004
467 LOCALISED INFECTION 9 0.0004
468 RHINITIS 3 0.0004
469 MENTAL IMPAIRMENT 9 0.0004
470 ANAL ABSCESS 2 0.0004
471 SWELLING FACE 24 0.0004
472 DRUG TOXICITY 5 0.0004
473 BLOOD POTASSIUM DECREASED 11 0.0004
474 NONSPECIFIC REACTION 2 0.0004
475 DEAFNESS UNILATERAL 2 0.0004
476 SPINAL COMPRESSION FRACTURE 3 0.0004
477 MEDICATION ERROR 20 0.0004
478 ABDOMINAL PAIN UPPER 74 0.0004
479 HAEMOPTYSIS 10 0.0004
480 APHONIA 5 0.0004
481 ADVERSE EVENT 33 0.0004
482 CRYING 13 0.0004
483 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
484 HEART RATE IRREGULAR 8 0.0004
485 BRONCHOSPASM 5 0.0004
486 SKIN IRRITATION 16 0.0003
487 RASH GENERALISED 9 0.0003
488 EXERCISE TOLERANCE DECREASED 2 0.0003
489 OFF LABEL USE 304 0.0003
490 PYELONEPHRITIS 3 0.0003
491 SKIN SWELLING 3 0.0003
492 LOCAL SWELLING 6 0.0003
493 CONDITION AGGRAVATED 104 0.0003
494 LUNG INFILTRATION 3 0.0003
495 INSOMNIA 90 0.0003
496 PLEURISY 2 0.0003
497 SINUS HEADACHE 2 0.0003
498 WRONG DRUG ADMINISTERED 3 0.0003
499 FACIAL PAIN 3 0.0003
500 MUSCULAR WEAKNESS 38 0.0003
501 RESPIRATORY DISORDER 10 0.0003
502 HEADACHE 209 0.0003
503 MOUTH ULCERATION 7 0.0003
504 HEPATITIS C 4 0.0003
505 PLATELET COUNT ABNORMAL 2 0.0003
506 INGUINAL HERNIA 2 0.0003
507 NO THERAPEUTIC RESPONSE 4 0.0003
508 MUSCLE SPASTICITY 4 0.0003
509 IRON DEFICIENCY ANAEMIA 3 0.0003
510 TENDONITIS 5 0.0003
511 INFLUENZA 36 0.0003
512 ERYTHEMA MULTIFORME 3 0.0003
513 APPLICATION SITE IRRITATION 4 0.0003
514 AGEUSIA 8 0.0003
515 DRY EYE 16 0.0003
516 SWOLLEN TONGUE 10 0.0003
517 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
518 NASAL DRYNESS 2 0.0003
519 SPUTUM DISCOLOURED 3 0.0003
520 PNEUMOTHORAX 5 0.0003
521 CYSTITIS 10 0.0003
522 SNEEZING 7 0.0003
523 DEPRESSION 71 0.0003
524 PROCTALGIA 2 0.0003
525 HAEMOGLOBIN ABNORMAL 2 0.0003
526 ANAPHYLACTIC SHOCK 8 0.0003
527 CHROMATURIA 7 0.0003
528 DYSSTASIA 9 0.0003
529 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
530 BRADYPHRENIA 2 0.0003
531 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
532 STAPHYLOCOCCAL INFECTION 10 0.0003
533 VENTRICULAR TACHYCARDIA 5 0.0003
534 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
535 DIZZINESS 149 0.0003
536 QUALITY OF LIFE DECREASED 4 0.0003
537 MOTOR DYSFUNCTION 3 0.0003
538 ABNORMAL LOSS OF WEIGHT 2 0.0003
539 METRORRHAGIA 5 0.0003
540 EYE MOVEMENT DISORDER 2 0.0003
541 AMNESIA 19 0.0003
542 ECCHYMOSIS 2 0.0003
543 GASTRIC DISORDER 10 0.0003
544 LARGE INTESTINE POLYP 2 0.0003
545 RESPIRATORY FAILURE 21 0.0003
546 ORAL DISCOMFORT 4 0.0003
547 NERVOUSNESS 15 0.0003
548 CARPAL TUNNEL SYNDROME 4 0.0003
549 APPLICATION SITE REACTION 2 0.0003
550 SKIN REACTION 4 0.0003
551 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
552 HAND FRACTURE 2 0.0003
553 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
554 BODY HEIGHT DECREASED 3 0.0003
555 PANIC REACTION 2 0.0003
556 WEIGHT INCREASED 62 0.0003
557 TOOTHACHE 5 0.0003
558 RASH PUSTULAR 2 0.0003
559 PARAESTHESIA 43 0.0003
560 RESTLESSNESS 10 0.0003
561 MOUTH HAEMORRHAGE 2 0.0003
562 GASTROINTESTINAL PAIN 3 0.0003
563 PERIPHERAL SWELLING 42 0.0003
564 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
565 ARTHROPOD BITE 2 0.0003
566 URINARY TRACT INFECTION 46 0.0003
567 HEPATOTOXICITY 6 0.0003
568 HYDRONEPHROSIS 2 0.0003
569 FISTULA 3 0.0003
570 GENERAL SYMPTOM 2 0.0003
571 PAROSMIA 2 0.0003
572 TENDON PAIN 2 0.0003
573 ECONOMIC PROBLEM 4 0.0003
574 MICTURITION URGENCY 3 0.0003
575 OEDEMA PERIPHERAL 32 0.0003
576 FALL 87 0.0003
577 SKIN DISCOLOURATION 12 0.0003
578 PROCEDURAL COMPLICATION 2 0.0003
579 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
580 THYROID DISORDER 4 0.0003
581 EMOTIONAL DISORDER 8 0.0003
582 GASTROINTESTINAL INFLAMMATION 2 0.0003
583 VAGINAL HAEMORRHAGE 11 0.0003
584 OCULAR HYPERAEMIA 12 0.0003
585 DIVERTICULITIS 7 0.0003
586 ABNORMAL BEHAVIOUR 10 0.0003
587 DISORIENTATION 10 0.0003
588 MENTAL STATUS CHANGES 7 0.0003
589 PREGNANCY 5 0.0002
590 TRANSPLANT REJECTION 2 0.0002
591 EYE PAIN 14 0.0002
592 MUSCLE TIGHTNESS 4 0.0002
593 BLOOD POTASSIUM INCREASED 4 0.0002
594 BACK DISORDER 4 0.0002
595 MUSCLE SPASMS 45 0.0002
596 FEELING HOT 15 0.0002
597 HYPERAESTHESIA 2 0.0002
598 ABASIA 6 0.0002
599 CYST 3 0.0002
600 PERITONITIS 5 0.0002
601 TOOTH EXTRACTION 3 0.0002
602 EPISTAXIS 18 0.0002
603 COAGULOPATHY 4 0.0002
604 URINARY RETENTION 8 0.0002
605 DRUG INTERACTION 38 0.0002
606 DERMATITIS 5 0.0002
607 DERMATITIS ALLERGIC 3 0.0002
608 RENAL FAILURE ACUTE 10 0.0002
609 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
610 RETCHING 5 0.0002
611 VISUAL IMPAIRMENT 29 0.0002
612 DIARRHOEA 151 0.0002
613 SKIN HYPERPIGMENTATION 2 0.0002
614 ANURIA 2 0.0002
615 APHASIA 7 0.0002
616 PRURITUS GENERALISED 5 0.0002
617 COMA 11 0.0002
618 RASH ERYTHEMATOUS 11 0.0002
619 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
620 DEAFNESS 6 0.0002
621 TREMOR 38 0.0002
622 ARTHRITIS 18 0.0002
623 COLD SWEAT 4 0.0002
624 OROPHARYNGEAL PAIN 21 0.0002
625 IMMUNOSUPPRESSION 2 0.0002
626 ARTHRALGIA 94 0.0002
627 PURPURA 2 0.0002
628 EYE IRRITATION 13 0.0002
629 PLATELET COUNT DECREASED 24 0.0002
630 MYOSITIS 2 0.0002
631 THROAT IRRITATION 10 0.0002
632 BLOOD BILIRUBIN INCREASED 6 0.0002
633 THROAT TIGHTNESS 6 0.0002
634 DEVELOPMENTAL DELAY 2 0.0002
635 PANIC ATTACK 8 0.0002
636 TREATMENT NONCOMPLIANCE 12 0.0002
637 CORONARY ARTERY OCCLUSION 3 0.0002
638 PERIPHERAL COLDNESS 3 0.0002
639 TINNITUS 10 0.0002
640 ABNORMAL DREAMS 6 0.0002
641 ANAPHYLACTIC REACTION 12 0.0002
642 NERVE COMPRESSION 2 0.0002
643 FLUSHING 22 0.0002
644 BREAST CANCER STAGE I 2 0.0002
645 SEPSIS 24 0.0002
646 BACTERIAL INFECTION 4 0.0002
647 BURNING SENSATION 15 0.0002
648 LACERATION 2 0.0002
649 ARTERIOSCLEROSIS 2 0.0002
650 DIALYSIS 3 0.0002
651 BLOOD URINE PRESENT 4 0.0002
652 CONVULSION 12 0.0002
653 INCREASED APPETITE 4 0.0002
654 CARDIOGENIC SHOCK 3 0.0002
655 GAIT DISTURBANCE 40 0.0002
656 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
657 PRURITUS 80 0.0002
658 PANCREATITIS 11 0.0002
659 APATHY 3 0.0002
660 DYSPHONIA 12 0.0002
661 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
662 INFLAMMATORY BOWEL DISEASE 2 0.0002
663 HEPATOMEGALY 2 0.0002
664 LABORATORY TEST ABNORMAL 6 0.0002
665 SKIN HAEMORRHAGE 3 0.0002
666 BLADDER DISORDER 2 0.0002
667 HYPOTONIA 2 0.0002
668 SPINAL FRACTURE 4 0.0002
669 LYMPHADENOPATHY 7 0.0002
670 EYELID PTOSIS 2 0.0002
671 SUBARACHNOID HAEMORRHAGE 2 0.0002
672 SKIN BURNING SENSATION 14 0.0002
673 NEUTROPHIL COUNT INCREASED 2 0.0002
674 EUPHORIC MOOD 2 0.0002
675 PHARYNGEAL OEDEMA 3 0.0002
676 TEMPERATURE INTOLERANCE 2 0.0002
677 PAIN IN EXTREMITY 57 0.0002
678 DELUSION 3 0.0002
679 HAEMATOMA 5 0.0002
680 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
681 FATIGUE 150 0.0002
682 SEDATION 5 0.0002
683 CYANOSIS 3 0.0002
684 HALLUCINATION, VISUAL 4 0.0002
685 HALLUCINATION, AUDITORY 3 0.0002
686 DYSGEUSIA 14 0.0002
687 ABSCESS 3 0.0002
688 FEELING ABNORMAL 45 0.0002
689 DYSARTHRIA 7 0.0002
690 FEAR 5 0.0002
691 POOR QUALITY SLEEP 4 0.0002
692 HALLUCINATION 14 0.0002
693 DISTURBANCE IN ATTENTION 10 0.0002
694 DECREASED ACTIVITY 2 0.0002
695 PHARYNGITIS STREPTOCOCCAL 2 0.0002
696 RASH PRURITIC 10 0.0002
697 ASTHENIA 69 0.0002
698 HEART RATE INCREASED 18 0.0002
699 TOOTH FRACTURE 2 0.0002
700 DRUG LEVEL INCREASED 3 0.0002
701 DEHYDRATION 24 0.0002
702 TOOTH DISORDER 4 0.0002
703 NERVE INJURY 2 0.0002
704 RASH MACULO-PAPULAR 4 0.0002
705 DRY SKIN 24 0.0002
706 BLOOD UREA INCREASED 3 0.0002
707 DYSPHAGIA 17 0.0002
708 THROMBOCYTOPENIA 20 0.0002
709 RASH PAPULAR 4 0.0002
710 SKIN INFECTION 2 0.0002
711 FACE OEDEMA 3 0.0002
712 CANDIDA INFECTION 3 0.0002
713 EYE INFECTION 2 0.0002
714 PAIN IN JAW 5 0.0002
715 IMPAIRED DRIVING ABILITY 2 0.0002
716 MYOCARDIAL ISCHAEMIA 2 0.0002
717 HAEMOGLOBIN DECREASED 18 0.0002
718 CHOLECYSTECTOMY 2 0.0002
719 MUSCULOSKELETAL DISCOMFORT 3 0.0002
720 PARANOIA 3 0.0002
721 LETHARGY 10 0.0002
722 GASTRIC HAEMORRHAGE 2 0.0002
723 MUSCLE TWITCHING 4 0.0002
724 NIGHTMARE 6 0.0002
725 HYPOKALAEMIA 8 0.0002
726 ORTHOSTATIC HYPOTENSION 3 0.0002
727 ELECTROLYTE IMBALANCE 2 0.0002
728 CAESAREAN SECTION 2 0.0002
729 MYALGIA 29 0.0002
730 URINARY INCONTINENCE 5 0.0002
731 MYOCLONUS 2 0.0002
732 GASTROENTERITIS VIRAL 3 0.0002
733 PREMATURE BABY 5 0.0002
734 SKIN EXFOLIATION 14 0.0002
735 LEUKOCYTOSIS 3 0.0002
736 INTERSTITIAL LUNG DISEASE 8 0.0002
737 PELVIC PAIN 3 0.0002
738 NEURALGIA 4 0.0002
739 LOSS OF CONSCIOUSNESS 21 0.0002
740 RESPIRATORY DEPRESSION 2 0.0002
741 HOSPITALISATION 25 0.0002
742 BLOOD GLUCOSE ABNORMAL 3 0.0002
743 GENERALISED OEDEMA 2 0.0002
744 ILEUS 2 0.0002
745 SECRETION DISCHARGE 2 0.0002
746 BLOOD SODIUM DECREASED 3 0.0002
747 CELLULITIS 8 0.0002
748 FOOT FRACTURE 3 0.0002
749 GASTRIC ULCER 3 0.0002
750 TACHYCARDIA 14 0.0002
751 SLEEP APNOEA SYNDROME 3 0.0002
752 HERPES ZOSTER 9 0.0002
753 HYPOPHAGIA 4 0.0002
754 CHOLESTASIS 3 0.0002
755 POST PROCEDURAL COMPLICATION 3 0.0002
756 DRUG PRESCRIBING ERROR 3 0.0002
757 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
758 MYDRIASIS 2 0.0002
759 ERECTILE DYSFUNCTION 4 0.0002
760 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
761 SKIN ULCER 4 0.0002
762 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
763 ANXIETY 44 0.0002
764 HIATUS HERNIA 2 0.0002
765 CHOKING 3 0.0002
766 ORAL HERPES 3 0.0002
767 BONE PAIN 9 0.0002
768 SPEECH DISORDER 8 0.0002
769 APPLICATION SITE ERYTHEMA 4 0.0002
770 BEDRIDDEN 2 0.0002
771 GASTRITIS 4 0.0002
772 IMMUNE SYSTEM DISORDER 2 0.0002
773 TOOTH INFECTION 2 0.0002
774 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
775 SINUS DISORDER 3 0.0002
776 CATARACT 9 0.0002
777 BLOOD PRESSURE ABNORMAL 3 0.0002
778 VISUAL ACUITY REDUCED 5 0.0002
779 BLOOD PRESSURE DECREASED 10 0.0002
780 EYE HAEMORRHAGE 2 0.0001
781 AGITATION 11 0.0001
782 MALIGNANT MELANOMA 2 0.0001
783 JAUNDICE 4 0.0001
784 ANGER 5 0.0001
785 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
786 ACUTE HEPATIC FAILURE 2 0.0001
787 HAEMATURIA 5 0.0001
788 UNEVALUABLE EVENT 11 0.0001
789 RESPIRATORY DISTRESS 4 0.0001
790 HYPOGLYCAEMIA 7 0.0001
791 POLLAKIURIA 6 0.0001
792 FEELING COLD 4 0.0001
793 RASH MACULAR 5 0.0001
794 HEPATOCELLULAR INJURY 2 0.0001
795 SINUS TACHYCARDIA 2 0.0001
796 JOINT INJURY 3 0.0001
797 AGGRESSION 7 0.0001
798 HYPERSOMNIA 4 0.0001
799 SKIN CANCER 3 0.0001
800 FAECES DISCOLOURED 3 0.0001
801 SEPTIC SHOCK 6 0.0001
802 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
803 SURGERY 8 0.0001
804 ACUTE MYOCARDIAL INFARCTION 4 0.0001
805 TRANSAMINASES INCREASED 3 0.0001
806 NEOPLASM MALIGNANT 9 0.0001
807 PANCREATITIS ACUTE 3 0.0001
808 BACK PAIN 31 0.0001
809 DRUG DOSE OMISSION 22 0.0001
810 HYPOAESTHESIA ORAL 2 0.0001
811 APPLICATION SITE PRURITUS 3 0.0001
812 HYPERHIDROSIS 17 0.0001
813 THERAPEUTIC RESPONSE DECREASED 8 0.0001
814 OSTEOPENIA 2 0.0001
815 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
816 DEVICE FAILURE 2 0.0001
817 SHOCK 3 0.0001
818 DRUG EFFECT DECREASED 7 0.0001
819 DEVICE RELATED INFECTION 2 0.0001
820 LYMPHOMA 2 0.0001
821 BASAL CELL CARCINOMA 2 0.0001
822 RENAL FAILURE 17 0.0001
823 CHILLS 15 0.0001
824 BLOOD GLUCOSE INCREASED 24 0.0001
825 BALANCE DISORDER 11 0.0001
826 PREMATURE DELIVERY 2 0.0001
827 METABOLIC ACIDOSIS 4 0.0001
828 BLOOD PRESSURE FLUCTUATION 3 0.0001
829 HAEMORRHAGE 13 0.0001
830 THROMBOSIS 10 0.0001
831 DYSKINESIA 5 0.0001
832 BLINDNESS 5 0.0001
833 ENCEPHALOPATHY 3 0.0001
834 VIRAL INFECTION 4 0.0001
835 SUICIDAL IDEATION 11 0.0001
836 PNEUMONIA ASPIRATION 3 0.0001
837 SKIN DISORDER 4 0.0001
838 RHABDOMYOLYSIS 5 0.0001
839 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
840 SOMNOLENCE 24 0.0001
841 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
842 ABDOMINAL PAIN LOWER 3 0.0001
843 HAEMATEMESIS 3 0.0001
844 HEMIPARESIS 2 0.0001
845 VISION BLURRED 16 0.0001
846 UNRESPONSIVE TO STIMULI 3 0.0001
847 HYPOTENSION 23 0.0001
848 ANGIOEDEMA 5 0.0001
849 GALLBLADDER DISORDER 2 0.0001
850 CARDIAC FAILURE CONGESTIVE 9 0.0001
851 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
852 RESTLESS LEGS SYNDROME 2 0.0001
853 SKIN LESION 3 0.0001
854 ACCIDENTAL OVERDOSE 4 0.0001
855 NEPHROLITHIASIS 5 0.0001
856 RENAL DISORDER 5 0.0001
857 MIDDLE INSOMNIA 2 0.0001
858 COGNITIVE DISORDER 5 0.0001
859 OXYGEN SATURATION DECREASED 6 0.0001
860 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
861 HYPOCALCAEMIA 2 0.0001
862 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
863 SEROTONIN SYNDROME 2 0.0001
864 ACUTE RESPIRATORY FAILURE 2 0.0001
865 ERUCTATION 2 0.0001
866 DYSTONIA 2 0.0001
867 PALPITATIONS 12 0.0001
868 KIDNEY INFECTION 2 0.0001
869 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
870 UPPER LIMB FRACTURE 2 0.0001
871 LEUKOPENIA 5 0.0001
872 ABORTION SPONTANEOUS 4 0.0001
873 IRRITABILITY 6 0.0001
874 HEPATIC FAILURE 3 0.0001
875 FEEDING DISORDER 2 0.0001
876 PLEURAL EFFUSION 6 0.0001
877 BONE MARROW FAILURE 2 0.0001
878 FLUID RETENTION 5 0.0001
879 NEUTROPHIL COUNT DECREASED 4 0.0001
880 BODY TEMPERATURE INCREASED 2 0.0001
881 NERVOUS SYSTEM DISORDER 3 0.0001
882 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
883 BONE DENSITY DECREASED 3 0.0001
884 ECZEMA 5 0.0001
885 BRADYCARDIA 5 0.0001
886 EATING DISORDER 2 0.0001
887 MOVEMENT DISORDER 3 0.0001
888 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
889 MENTAL DISORDER 4 0.0001
890 PRODUCT PRESCRIBING ISSUE 2 0.0001
891 CHOLELITHIASIS 3 0.0001
892 EYE DISORDER 3 0.0001
893 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
894 APPLICATION SITE PAIN 2 0.0001
895 FEBRILE NEUTROPENIA 6 0.0001
896 EXPIRED PRODUCT ADMINISTERED 3 0.0001
897 EYE PRURITUS 3 0.0001
898 HYPONATRAEMIA 5 0.0001
899 PERICARDIAL EFFUSION 2 0.0001
900 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
901 HYPERKALAEMIA 3 0.0001
902 BLOOD PRESSURE INCREASED 13 0.0001
903 CEREBRAL HAEMORRHAGE 3 0.0001
904 SUICIDE ATTEMPT 5 0.0001
905 ATRIAL FIBRILLATION 8 0.0001
906 VERTIGO 5 0.0001
907 CEREBRAL INFARCTION 2 0.0001
908 INJECTION SITE URTICARIA 2 0.0001
909 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
910 EXTRAPYRAMIDAL DISORDER 2 0.0001
911 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
912 HEPATIC FUNCTION ABNORMAL 3 0.0001
913 INTESTINAL OBSTRUCTION 3 0.0001
914 CARDIOVASCULAR DISORDER 2 0.0001
915 DIABETES MELLITUS 6 0.0001
916 INTENTIONAL OVERDOSE 5 0.0001
917 DRUG RESISTANCE 2 0.0001
918 DIPLOPIA 2 0.0001
919 DEEP VEIN THROMBOSIS 5 0.0001
920 PSORIASIS 10 0.0001
921 MUCOSAL INFLAMMATION 2 0.0001
922 DISEASE PROGRESSION 9 0.0001
923 PALLOR 2 0.0001
924 PNEUMONITIS 2 0.0001
925 MOOD ALTERED 2 0.0001
926 LUNG NEOPLASM MALIGNANT 3 0.0001
927 CARDIAC ARREST 6 0.0001
928 RESPIRATORY ARREST 2 0.0001
929 TARDIVE DYSKINESIA 2 0.0001
930 FLATULENCE 4 0.0001
931 SYNCOPE 7 0.0001
932 HYPOACUSIS 3 0.0001
933 LIVER FUNCTION TEST ABNORMAL 2 0.0001
934 NEEDLE ISSUE 2 0.0001
935 INTENTIONAL PRODUCT MISUSE 6 0.0001
936 ASCITES 2 0.0001
937 RENAL INJURY 2 0.0001
938 PULMONARY OEDEMA 3 0.0001
939 CORONARY ARTERY DISEASE 2 0.0001
940 LIMB DISCOMFORT 2 0.0001
941 ARRHYTHMIA 3 0.0001
942 HEAD INJURY 2 0.0001
943 MYOCARDIAL INFARCTION 11 0.0001
944 HYPOTHYROIDISM 2 0.0001
945 BLOOD GLUCOSE DECREASED 3 0.0001
946 CARDIAC FAILURE 5 0.0001
947 HIP FRACTURE 2 0.0001
948 LACTIC ACIDOSIS 2 0.0001
949 BLOOD CREATININE INCREASED 4 0.0001
950 INFLUENZA LIKE ILLNESS 5 0.0001
951 TOXICITY TO VARIOUS AGENTS 10 0.0001
952 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
953 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
954 HEART RATE DECREASED 2 0.0001
955 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
956 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
957 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
958 HYPERGLYCAEMIA 2 0.0001
959 PANCYTOPENIA 3 0.0001
960 CARDIAC DISORDER 5 0.0001
961 CHRONIC KIDNEY DISEASE 4 0.0001
962 PULMONARY EMBOLISM 5 0.0001
963 DEATH 44 0.0001
964 EXTRA DOSE ADMINISTERED 2 0.0000
965 CARDIO-RESPIRATORY ARREST 2 0.0000
966 RENAL IMPAIRMENT 4 0.0000
967 MULTIPLE SCLEROSIS 2 0.0000
968 HOT FLUSH 3 0.0000
969 THERAPY CESSATION 2 0.0000
970 ILLNESS 4 0.0000
971 DERMATITIS ATOPIC 2 0.0000
972 INJECTION SITE HAEMORRHAGE 3 0.0000
973 COMPLETED SUICIDE 3 0.0000
974 CEREBROVASCULAR ACCIDENT 6 0.0000
975 INCORRECT DOSE ADMINISTERED 8 0.0000
976 PRODUCT SUBSTITUTION ISSUE 2 0.0000
977 SEIZURE 4 0.0000
978 DRUG WITHDRAWAL SYNDROME 3 0.0000
979 PRODUCT DOSE OMISSION ISSUE 10 0.0000
980 BLADDER CANCER 2 0.0000
981 NO ADVERSE EVENT 6 0.0000
982 INJECTION SITE ERYTHEMA 4 0.0000
983 BREAST CANCER 3 0.0000
984 NEUTROPENIA 4 0.0000
985 INJECTION SITE PAIN 9 0.0000
986 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
987 THERAPY INTERRUPTED 2 0.0000
988 INJECTION SITE BRUISING 2 0.0000
989 DRUG DEPENDENCE 3 0.0000
990 EMOTIONAL DISTRESS 2 0.0000
991 ACUTE KIDNEY INJURY 2 0.0000